The Short-term Effect of a Single Lapse in Anti–Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema Within Routine Clinical Practice

PURPOSE: Diabetic macular edema (DME) is a leading cause of vision loss in diabetics. Anti–vascular endothelial growth factor (VEGF) therapy has been shown to be an effective treatment option for DME, although the injections are costly and require frequent visits, which increases the risk for uninte...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalamanchili, Siri P., Maatouk, Christopher M., Enwere, Daniel U., Conti, Thais F., Hom, Grant L., Briskin, Isaac N., Greenlee, Tyler E., Babiuch, Amy S., Singh, Rishi P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335491/
https://www.ncbi.nlm.nih.gov/pubmed/32640254
http://dx.doi.org/10.1016/j.ajo.2020.06.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335491/
https://www.ncbi.nlm.nih.gov/pubmed/32640254
http://dx.doi.org/10.1016/j.ajo.2020.06.040

Ejemplares similares